A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients
Clinical trial NCT00645372 · COMPLETED
Trial details
- NCT number
- NCT00645372
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.